File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Interim analysis of hepatitis B reactivation in patients with prior HBV exposure undergoing rituximab-containing chemotherapy: a prospective study

TitleInterim analysis of hepatitis B reactivation in patients with prior HBV exposure undergoing rituximab-containing chemotherapy: a prospective study
Authors
Issue Date2013
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/
Citation
The 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD): The Liver Meeting, Washington, DC, USA, 1-5 November 2013. In Hepatology, 2013, v. 28 n. Suppl. 1, p. 224A, abstract no. 34 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/198622
ISSN
2015 Impact Factor: 11.711
2015 SCImago Journal Rankings: 4.752

 

DC FieldValueLanguage
dc.contributor.authorSeto, WKWen_US
dc.contributor.authorChan, TSen_US
dc.contributor.authorHwang, YYGen_US
dc.contributor.authorChoi, Oen_US
dc.contributor.authorWong, DKHen_US
dc.contributor.authorFung, JYYen_US
dc.contributor.authorLie, AKWen_US
dc.contributor.authorLai, CLen_US
dc.contributor.authorKwong, YLen_US
dc.contributor.authorYuen, RMFen_US
dc.date.accessioned2014-07-07T08:14:43Z-
dc.date.available2014-07-07T08:14:43Z-
dc.date.issued2013en_US
dc.identifier.citationThe 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD): The Liver Meeting, Washington, DC, USA, 1-5 November 2013. In Hepatology, 2013, v. 28 n. Suppl. 1, p. 224A, abstract no. 34en_US
dc.identifier.issn0270-9139-
dc.identifier.urihttp://hdl.handle.net/10722/198622-
dc.languageengen_US
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/-
dc.relation.ispartofHepatologyen_US
dc.rightsHepatology. Copyright © John Wiley & Sons, Inc.-
dc.titleInterim analysis of hepatitis B reactivation in patients with prior HBV exposure undergoing rituximab-containing chemotherapy: a prospective studyen_US
dc.typeConference_Paperen_US
dc.identifier.emailSeto, WKW: wkseto2@hku.hken_US
dc.identifier.emailHwang, YYG: yyhwang@hku.hken_US
dc.identifier.emailWong, DKH: danywong@hku.hken_US
dc.identifier.emailFung, JYY: jfung@hkucc.hku.hken_US
dc.identifier.emailLie, AKW: akwlie@hkucc.hku.hken_US
dc.identifier.emailLai, CL: hrmelcl@hku.hken_US
dc.identifier.emailKwong, YL: ylkwong@hku.hken_US
dc.identifier.emailYuen, RMF: mfyuen@hku.hken_US
dc.identifier.authoritySeto, WKW=rp01659en_US
dc.identifier.authorityWong, DKH=rp00492en_US
dc.identifier.authorityFung, JYY=rp00518en_US
dc.identifier.authorityLai, CL=rp00314en_US
dc.identifier.authorityKwong, YL=rp00358en_US
dc.identifier.doi10.1002/hep.26727-
dc.identifier.hkuros229848en_US
dc.identifier.volume28-
dc.identifier.issueSuppl. 1-
dc.identifier.spage224A, abstract no. 34-
dc.identifier.epage224A, abstract no. 34-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats